• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌外科病理学中 pT 亚分类的临床意义。

Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.

机构信息

Institute of Pathology, Medical University, Auenbruggerplatz 25, 8036 Graz, Austria.

出版信息

Int J Colorectal Dis. 2010 Feb;25(2):187-96. doi: 10.1007/s00384-009-0801-4. Epub 2009 Oct 9.

DOI:10.1007/s00384-009-0801-4
PMID:19816699
Abstract

PURPOSE

Tumour stage is the strongest prognostic parameter in colorectal cancer. The study aimed to evaluate the prognostic impact of pT2, pT3, and pT4 sub-classification.

METHODS

Three hundred eighty-one surgical colorectal cancer specimens were retrospectively re-evaluated. pT2 tumours were sub-classified according to infiltration of the inner circumferential (pT2a) or outer longitudinal (pT2b) layer of the muscularis propria. pT3 tumours were sub-classified by measuring the maximal tumour invasion beyond the outer border of the muscularis propria (pT3a <or= 1 mm, pT3b > 1-5 mm, pT3c > 5-15 mm, and pT3d > 15 mm). pT4 tumours were sub-classified according to invasion of other organs or structures (pT4a) or perforation of the visceral peritoneum (pT4b). Data were correlated with other pathological parameters and patient outcome.

RESULTS

Seventy pT2 tumours were re-classified as 37 pT2a and 33 pT2b tumours. There was no significant association with tumour grade, angioinvasion, or lymph node involvement and no significant impact on prognosis. Two hundred eighteen pT3 tumours were re-classified as 49 pT3a, 83 pT3b, 53 pT3c, and 33 pT3d tumours. pT3 sub-classification was significantly associated with tumour grade, angioinvasion, and lymph node involvement and proved to be an independent prognostic variable with respect to progression-free and cancer-specific survival. A cut-off level of 5 mm is recommended. Sixty-five pT4 tumours were re-classified as 15 pT4a and 50 pT4b tumours. There was no significant association with tumour grade, angioinvasion, or lymph node involvement and no significant impact on prognosis.

CONCLUSIONS

pT3 sub-classification was significantly associated with patient outcome. In contrast, pT2 and pT4 sub-classification did not show clinical significance.

摘要

目的

肿瘤分期是结直肠癌最强的预后参数。本研究旨在评估 pT2、pT3 和 pT4 亚分类的预后影响。

方法

回顾性评估 381 例结直肠手术标本。pT2 肿瘤根据固有肌层内环层(pT2a)或外纵层(pT2b)的浸润进行亚分类。pT3 肿瘤通过测量固有肌层外边界以外的最大肿瘤浸润程度进行亚分类(pT3a≤1mm、pT3b>1-5mm、pT3c>5-15mm 和 pT3d>15mm)。pT4 肿瘤根据侵犯其他器官或结构(pT4a)或穿透内脏腹膜(pT4b)进行亚分类。将数据与其他病理参数和患者预后相关联。

结果

70 例 pT2 肿瘤重新分类为 37 例 pT2a 和 33 例 pT2b 肿瘤。与肿瘤分级、血管侵犯或淋巴结受累无显著相关性,对预后无显著影响。218 例 pT3 肿瘤重新分类为 49 例 pT3a、83 例 pT3b、53 例 pT3c 和 33 例 pT3d 肿瘤。pT3 亚分类与肿瘤分级、血管侵犯和淋巴结受累显著相关,是无进展生存期和癌症特异性生存期的独立预后变量。建议截断值为 5mm。65 例 pT4 肿瘤重新分类为 15 例 pT4a 和 50 例 pT4b 肿瘤。与肿瘤分级、血管侵犯或淋巴结受累无显著相关性,对预后无显著影响。

结论

pT3 亚分类与患者预后显著相关。相比之下,pT2 和 pT4 亚分类没有显示出临床意义。

相似文献

1
Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.结直肠癌外科病理学中 pT 亚分类的临床意义。
Int J Colorectal Dis. 2010 Feb;25(2):187-96. doi: 10.1007/s00384-009-0801-4. Epub 2009 Oct 9.
2
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
3
Retinoblastoma Outcomes Based on the 8th Edition American Joint Committee on Cancer Pathological Classification in 1411 Patients.基于美国癌症联合委员会第8版病理分类的1411例视网膜母细胞瘤患者的预后情况
Ophthalmology. 2025 Mar;132(3):317-326. doi: 10.1016/j.ophtha.2024.08.037. Epub 2024 Sep 7.
4
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.国际验证 AJCC 分期 pT3 肾盂上尿路上皮癌亚分类的预后价值。
BJU Int. 2012 Sep;110(5):674-81. doi: 10.1111/j.1464-410X.2012.10930.x. Epub 2012 Feb 20.
5
The prognostic inhomogeneity in pT3 rectal carcinomas.pT3期直肠癌的预后异质性。
Int J Colorectal Dis. 2001 Sep;16(5):298-304. doi: 10.1007/s003840100309.
6
Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?淋巴结阳性结直肠癌中记录淋巴血管侵犯是否有依据?
J Clin Pathol. 2012 Sep;65(9):847-50. doi: 10.1136/jclinpath-2012-200817. Epub 2012 May 8.
7
Proposal of a T3 Subclassification for Colon Carcinoma.结肠癌T3亚分类的提议。
Cancers (Basel). 2022 Dec 14;14(24):6186. doi: 10.3390/cancers14246186.
8
Prognostic subdivision of pT2 rectal carcinomas.pT2期直肠癌的预后细分
Int J Colorectal Dis. 2019 Mar;34(3):409-415. doi: 10.1007/s00384-018-3216-2. Epub 2018 Dec 4.
9
Analysis of lymph node metastatic pattern according to the depth of in-growth in the muscularis propria in T2 rectal cancer for lateral lymph node dissection.分析 T2 期直肠癌肌层内浸润深度与侧方淋巴结转移模式及行侧方淋巴结清扫的关系。
Dig Surg. 2011;28(5-6):352-9. doi: 10.1159/000332825. Epub 2011 Oct 28.
10
Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.pT3和pT4期直肠腺癌的壁外神经侵犯作为术前放化疗后的预后因素
Hum Pathol. 2017 Jul;65:107-112. doi: 10.1016/j.humpath.2017.03.027. Epub 2017 May 16.

引用本文的文献

1
The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer.肿瘤细胞与腹膜表面之间的测量距离可预测腹膜转移的风险,并提供了一种客观的方法来区分 pT3 和 pT4a 期结肠癌。
Mod Pathol. 2022 Dec;35(12):1991-2001. doi: 10.1038/s41379-022-01154-z. Epub 2022 Sep 19.
2
Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer.辅助组织学特征对病理 T3 期结肠癌亚型分类的预后意义。
Int J Clin Oncol. 2022 Sep;27(9):1428-1438. doi: 10.1007/s10147-022-02192-y. Epub 2022 Jun 18.
3

本文引用的文献

1
Optimal pathologic staging: defining stage II disease.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6862s-70s. doi: 10.1158/1078-0432.CCR-07-1398.
2
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference.评估和治疗早期结肠癌和直肠癌的新方法:2007年圣莫尼卡会议总结声明
Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6853s-6s. doi: 10.1158/1078-0432.CCR-07-1629.
3
The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer.临床病理分期为B期和C期的直肠癌切除术后,游离浆膜面受累对复发和生存的意义。
Concordance and survival implications of preoperative subclassification of T3 rectal cancers by depth of mesorectal invasion using a 5-mm cut-off point with endorectal ultrasound and magnetic resonance imaging.
使用直肠内超声和磁共振成像,以5毫米为截断点,根据直肠系膜侵犯深度对T3期直肠癌进行术前亚分类的一致性及生存意义。
Quant Imaging Med Surg. 2022 Apr;12(4):2356-2367. doi: 10.21037/qims-21-880.
4
Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal Cancer.T4a和T4b期结直肠癌的长期生存结果比较。
Front Oncol. 2022 Jan 6;11:780684. doi: 10.3389/fonc.2021.780684. eCollection 2021.
5
Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort.超越 NCCN 结肠癌风险因素:在瑞典基于人群队列中的评估。
Ann Surg Oncol. 2020 Apr;27(4):1036-1045. doi: 10.1245/s10434-019-08148-3. Epub 2020 Jan 1.
6
How Should Imaging Direct/Orient Management of Rectal Cancer?影像学应如何指导/定位直肠癌的治疗?
Clin Colon Rectal Surg. 2017 Nov;30(5):297-312. doi: 10.1055/s-0037-1606107. Epub 2017 Nov 27.
7
Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer.IIA 期(pT3N0)结肠癌中,肿瘤浆膜外延伸作为术后辅助化疗的指征。
J Surg Oncol. 2013 Nov;108(6):358-63. doi: 10.1002/jso.23407. Epub 2013 Aug 23.
8
Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy.术前未接受放化疗的pT3N1-2期直肠癌患者中测量直肠系膜侵犯范围的益处:术后治疗策略
Exp Ther Med. 2013 Mar;5(3):661-666. doi: 10.3892/etm.2012.858. Epub 2012 Dec 14.
9
Has the new TNM classification for colorectal cancer improved care?结直肠癌的新 TNM 分期是否改善了治疗效果?
Nat Rev Clin Oncol. 2011 Oct 18;9(2):119-23. doi: 10.1038/nrclinonc.2011.157.
Colorectal Dis. 2007 Sep;9(7):609-18. doi: 10.1111/j.1463-1318.2006.01136.x.
4
The future of the TNM staging system in colorectal cancer: time for a debate?结直肠癌TNM分期系统的未来:是时候展开一场辩论了吗?
Lancet Oncol. 2007 Jul;8(7):651-7. doi: 10.1016/S1470-2045(07)70205-X.
5
Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer.影响pT1和pT2期结直肠癌患者生存及复发的预后因素。
World J Surg. 2007 Jul;31(7):1485-90. doi: 10.1007/s00268-007-9089-0. Epub 2007 May 18.
6
Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.T3N0(IIA期)结肠癌切除术后生存的病理决定因素:一种新的预后模型的建议
Dis Colon Rectum. 2007 Sep;50(9):1332-41. doi: 10.1007/s10350-007-0222-9.
7
Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.1676例未接受术前放疗的T3期直肠癌患者的预后分组
Dis Colon Rectum. 2007 Feb;50(2):156-67. doi: 10.1007/s10350-006-0757-1.
8
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.I期(pT1和pT2)结直肠腺癌组织学特征和生物学参数的预后意义
Pathol Res Pract. 2006;202(9):663-70. doi: 10.1016/j.prp.2006.05.003. Epub 2006 Jul 24.
9
Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients.直肠系膜肿瘤浸润范围作为T3期直肠癌患者根治性手术后的一个预后因素。
Ann Surg. 2006 Apr;243(4):492-8. doi: 10.1097/01.sla.0000205627.05769.08.
10
Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer.常见癌症标本报告中的关键问题:结肠癌病理分期的问题
Arch Pathol Lab Med. 2006 Mar;130(3):318-24. doi: 10.5858/2006-130-318-KIIRCC.